Literature DB >> 23217068

Extended and continuous combined contraceptive regimens for menstrual suppression.

Janet C Jacobson, Frances E Likis, Patricia Aikins Murphy.   

Abstract

Many women have medical indications for menstrual suppression or a personal preference to reduce or eliminate monthly bleeding, which can be achieved with extended and continuous regimens of combined estrogen and progestin contraceptives. Combined contraceptives are traditionally administered in a 28-day cycle, with 21 days of a contraceptive pill, vaginal ring, or transdermal patch followed by a hormone-free interval that is usually 7 days. During the hormone-free interval, women either take a placebo pill or do not use their combined contraceptive method. Hormone-related symptoms are significantly worse during the hormone-free interval than the days when the contraceptive is used. Alterations of the standard 28-day cyclic regimen for menstrual suppression include decreasing the frequency of the hormone-free interval, thus extending the time between withdrawal bleeding episodes (extended use), and eliminating the hormone-free interval altogether (continuous use). This article reviews menstrual suppression indications and physiology. Research demonstrating that the effectiveness, safety, and side effects of oral, vaginal, and transdermal extended and continuous regimens are comparable to cyclic regimens is summarized. Findings from studies of women's and health care providers' attitudes toward menstrual suppression also are reviewed. Important topics to include in evidence-based counseling for extended and continuous combined contraceptive use are presented.
© 2012 by the American College of Nurse-Midwives.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23217068     DOI: 10.1111/j.1542-2011.2012.00250.x

Source DB:  PubMed          Journal:  J Midwifery Womens Health        ISSN: 1526-9523            Impact factor:   2.388


  4 in total

1.  The effect of pycnogenol on patients with dysmenorrhea using low-dose oral contraceptives.

Authors:  Hugo Maia; Clarice Haddad; Julio Casoy
Journal:  Int J Womens Health       Date:  2014-12-11

Review 2.  CE: An Evidence-Based Update on Contraception.

Authors:  Laura E Britton; Amy Alspaugh; Madelyne Z Greene; Monica R McLemore
Journal:  Am J Nurs       Date:  2020-02       Impact factor: 2.577

Review 3.  Menstrual suppression: current perspectives.

Authors:  Paula Adams Hillard
Journal:  Int J Womens Health       Date:  2014-06-23

Review 4.  Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians.

Authors:  Rossella E Nappi; Andrew M Kaunitz; Johannes Bitzer
Journal:  Eur J Contracept Reprod Health Care       Date:  2015-11-17       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.